MyMD Pharmaceuticals^® Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1^® for Extending Healthy Lifespan

November 17, 2021

Believed to be the only IND application ever cleared by the FDA for a Phase 2 trial of a patented drug for delaying aging.

MyMD Pharmaceuticals® Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1® for Extending Healthy Lifespan